U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping more than 100 points on Friday.
The Dow traded up 0.69% to 33,086.43 while the NASDAQ rose 1.01% to 12,134.43. The S&P 500, also rose, gaining, 0.78% to 4,082.51.
An expert review of data from 79 real-world studies showed that AstraZeneca's COVID-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]) and the available mRNA COVID-19 vaccines provide equally effective protection against hospitalisation and death from COVID-19 following two doses.1